Visualitzant O - Articles científics per títol

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

Girard, Nicolas; Ponce Aix, Santiago; cedres, susana; Berghmans, Thierry; Burgers, Sjaak; Toffart, Anne-Claire (Elsevier, 2023-06)

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study

Algazi, Alain; Longo, Federico; Miller, Wilson; Bing, Jerry Tan Chun; OH, DO-YOUN; Capdevila Castillon, Jaume (Wiley, 2023-04-15)

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Makker, Vicky; González Martín , Antonio ; Meric-Bernstam, Funda; OAKNIN, ANA; OH, DO-YOUN; Banerjee, Susana (American Society of Clinical Oncology, 2024-01)

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)

Shitara, Kohei; Doi, Toshihiko; Hosaka, Hisashi; Santoro, Armando; Longo-Muñoz, Federico; Alsina Maqueda, Maria; Thuss-Patience, Peter (Springer, 2022-05)

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

Mitjavila Casanovas, Mercedes; Jimenez Fonseca, Paula; BELLO, PILAR; Pubul Núñez, Virginia; Percovich, Juan Carlos; Garcia-Burillo, Amparo; Hernando Cubero, Jorge (Springer, 2023-07)

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort

Cedres Perez, Susana; Assaf, Juan David; Iranzo Gómez, Patricia; Callejo Perez, Ana; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Marmolejo Castañeda, David; Rezqallah Aron, Maria Alejandra; Amat, Ramon; Pedrola Gómez, Anna; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan; Dienstmann, Rodrigo (Nature Research, 2021-11-01)

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

O’Shaughnessy, Joyce; Cortés Castan, Javier; Twelves, Chris; Goldstein, Lori J.; Alexis, Karenza; Xie, Ran (Nature Research, 2020-07-08)

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial

Im, Seock-Ah; Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe (American Medical Association, 2021-04)

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial

Hurvitz, Sara; Antunes de Melo Oliveira, Ana Mafalda; Trudeau, Maureen E.; Moy, Beverly; Saura Manich, Cristina; Delaloge, Suzette (Wiley, 2021-08)

eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability

Casacuberta-Serra, Sílvia; González-Larreategui, Íñigo; Soucek, Laura (AME Publishing, 2023-12-26)

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Bidard, François-Clement; Kaklamani, Virginia; Neven, Patrick; Streich, Guillermo; Montero, Alberto J.; Forget, Frédéric; Cortés Castan, Javier (American Society of Clinical Oncology, 2022-10-01)

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Kerzeli, Iliana K.; Kostakis, Alexandros; Turker, Polat; malmström, per-uno; Hemdan, Tammer; Mezheyeuski, Artur (BMC, 2023-06-30)

Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA

Sumanasuriya, Semini; Seed, George; Parr, Harry; Christova, Rossitza; Pope, Lorna; Bertan, Claudia; Mateo Valderrama, Joaquim (Elsevier, 2021-08)

Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach

Lozano, Maria L.; Segú-Vergés, Cristina; Coma, Mireia; González-Porras, José R.; Gutiérrez, Laura; Valcarcel Ferreiras, David; Álvarez Román, María Teresa (MDPI, 2021-07)

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer

Oaknin Benzaquen, Ana Mazaltob; Monk, Bradley J.; de Melo, Andreia Cristina; Kim, Yong-Man; Lisyanskaya, Alla; Vergote, Ignace (Elsevier, 2022-10)

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

DE BOTTON, stephane; Montesinos, Pau; Schuh, Andre C.; PAPAYANNIDIS, CRISTINA; Vyas, Paresh; Wei, Andrew H.; Salamero, Olga (American Society of Hematology, 2023-01-12)

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design

Riely, Gregory; Ahn, Myung-Ju; Felip Font, Enriqueta; Ramalingam, Suresh; Tsao, Anne; Smit, Egbert (Future Medicine, 2022-03)

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

Tabernero Caturla, Josep; Grothey, Axel; Van Cutsem, Eric; Wasan, Harpreet; Yoshino, Takayuki; Yaeger, Rona (American Society of Clinical Oncology, 2021-02-01)

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer

Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Saoudi Gonzalez, Nadia (SAGE Publications, 2022-07-04)

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO

Cappelletti, Vera; Silvestri, Marco; El-Abed, Sarra; Nuciforo, Paolo Giovanni; Di Cosimo, Serena; Ciniselli, Chiara Maura; Pizzamiglio, Sara (Frontiers Media, 2023-01-31)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial

eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA

Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial ﻿

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study ﻿

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial ﻿

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS) ﻿

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study ﻿

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort ﻿

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis ﻿

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial ﻿

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial ﻿

eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability ﻿

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial ﻿

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer ﻿

Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA ﻿

Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach ﻿

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer ﻿

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial ﻿

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design ﻿

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study ﻿

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer ﻿

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial

eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA

Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO